Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
New therapeutic targets for osteoporosis: Beyond denosumab
Vivien Lim,
Bart L. Clarke
Endocrinology, Diabetes, Metabolism, and Nutrition
Research output
:
Contribution to journal
›
Review article
›
peer-review
23
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'New therapeutic targets for osteoporosis: Beyond denosumab'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Denosumab
78%
Osteoporosis
49%
Osteogenesis
49%
Bone Density Conservation Agents
40%
Anabolic Agents
37%
Biological Factors
29%
Bone Density
25%
Cathepsin K
19%
Teriparatide
19%
Nasal Sprays
19%
Raloxifene Hydrochloride
19%
Selective Estrogen Receptor Modulators
18%
Catenins
17%
Bone and Bones
16%
Calcitonin
16%
Wnt Signaling Pathway
15%
Diphosphonates
15%
Osteoclasts
14%
Parathyroid Hormone
14%
Osteoblasts
13%
Anti-Idiotypic Antibodies
11%
Hormones
9%
Therapeutics
9%
Clinical Trials
9%
Enzymes
7%
Chemical Compounds
Antiresorptive
100%
Anabolic
53%
Biologic Agent
52%
Teriparatide
39%
Nasal Spray
33%
Anabolic Agent
30%
Raloxifene
30%
Selective Estrogen Receptor Modulator
30%
Calcitonin
26%
Parathyroid Hormone
26%
Digestive
23%
Hormone
18%